Science Videos

from AP, Reuters, AFP, and other news services

Curing hepatitis c

Date:
September 12, 2013
Source:
Ivanhoe / Powered by NewsLook.com
Summary:
Hepatitis C affects more than four-million people. The deadly disease can lead to liver cancer. Now there is a new era of drugs that could cure the disease, without side effects.


Related Videos

last updated on 2014-10-26 at 12:31 am EDT

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
New Vaccine Cures HIV Like Infection in Monkeys

New Vaccine Cures HIV Like Infection in Monkeys

Newsy (Sep. 11, 2013) — The vaccine successfully treated 9 out of 16 monkeys, essentially curing them of the deadly disease. The study was published in the journal Nature.
Powered by NewsLook.com
Stem Cells Could Produce Insulin

Stem Cells Could Produce Insulin

Newsy (Oct. 10, 2014) — A team of scientists at Harvard seems to have taken a crucial step toward eventually curing diabetes by creating insulin-producing beta cells. Video provided by Newsy
Powered by NewsLook.com
New Vaccine Brings Hope for Hepatitis B Eradication

New Vaccine Brings Hope for Hepatitis B Eradication

Reuters (Aug. 5, 2013) — Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to stop the disease in its tracks and is currently seeking approval for its use in the United States and Europe.
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins